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The osseous pelvis is a well-recognized site of origin of numerous primary and secondary musculoskeletal tumors. The radiologic
evaluation of a pelvic lesion often begins with the plain ﬁlm and proceeds to computed tomography (CT), or magnetic resonance
imaging(MRI)andpossiblybiopsy.Eachofthesemodalities,withinherentadvantagesanddisadvantages,hasaroleintheworkup
of pelvic osseous masses. Clinical history and imaging characteristics can signiﬁcantly narrow the broad diﬀerential diagnosis for
osseous pelvic lesions. The purpose of this review is to familiarize the radiologist with the presentation and appearance of some of
the common benign neoplasms of the osseous pelvis and share our experience and approach in diagnosing these lesions.
1.Introduction
The bony pelvis is a well-recognized site of origin of nu-
merous primary and secondary musculoskeletal tumors. In
adulthood, the pelvis is one of the areas of the axial skeleton
where haematopoietic red marrow predominates. The spe-
ciﬁc radiological diagnosis of primary pelvic tumors is often
diﬃcult, due to their varied appearance and overlapping
radiological features. The aim of this review is to familiarize
radiologists with the multimodality appearances of benign
neoplasms of the bony pelvis.
One of the main challenges in diagnosing tumors of
the pelvis lies in the low sensitivity of plain radiographic
detection (Figures 1(a),a n d1(b)). Unless there is gross
cortical destruction, extensive periosteal reaction or a large
soft tissue component, with or without calciﬁcation, pelvic
tumors are often not obvious on plain radiographs. Plain
radiography is the initial screening modality for most
symptomatic patients; thus, a proper history including age,
rate of onset, and duration of symptoms is necessary to
raise the level of suspicion. In addition, a pelvic tumor is
oftenobscuredonthefrontalprojection,furthercomplicated
by overlying bowel gas. There should therefore be a low
threshold for requesting multiple views (inlet view, outlet
view, judet view, etc.) of the pelvis. Often these lesions are
best visualized on non-AP radiographs. Assessment of pelvic
bones should be an integral part of the reporting process of
all abdominal ﬁlms.
2.ImagingTechniques
Multimodality imaging and a combined multidisciplinary
approach (radiologist, orthopedic surgeon, pathologist, and
primary care physician) is essential in accurate assessment
and staging of the tumor involved and facilitation of good
patient care. While the innovative technology of cross-
sectional imaging is useful for accurate staging and deﬁning
the local extent of the disease, the plain ﬁlm appearance is
most helpful in providing the diﬀerential diagnosis. Debate
exists as to which modality, CT or MR, is better in charac-
terizing the tumors. Unlike soft tissue tumors, where MR has
a distinct advantage, MR and CT are often complimentary2 The Scientiﬁc World Journal
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Figure 1: Middle-aged female presents with chronic pelvic pain. Frontal radiograph (a) of the abdomen reveals subtle cortical disruption
and periosteal reaction involving the superior aspect of the right iliac crest (arrow). Subsequent CT examination (b) demonstrates a lytic
destructive lesion of the right iliac bone, with a large soft tissue mass (asterisk).
(a) (b)
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Figure 2: 31-year-old male presents with palpable hard mass lateral to right iliac crest diagnosed as an osteochondroma. Pelvic plain ﬁlm (a)
demonstrates an irregularly calciﬁed, pedunculated lesion (asterisk) arising from the right iliac crest. It presents as a peripheral outgrowth
with its cortex in continuity with the iliac bone (arrowheads). Axial T1 (b) and axial T2 fat sat. (c) MRI images of same lesion (asterisk)
demonstrate the continuity of the cortex and medullary portion of the lesion with the parent bone (arrow) and identify a thin cartilage cap
(arrowheads).The Scientiﬁc World Journal 3
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Figure 3: 50-year-old male with osteoblastoma (aka giant osteoid osteoma) involving the left iliac bone. Plain radiograph (a) shows a
large lytic left iliac bone lesion (asterisk) with sharp sclerotic borders. An angiographic image (b) with a 5 French cobra catheter (curved
arrow) in the left common iliac artery demonstrates the vascular nature of the tumor, with the tumor blush (asterisk) predominantly
supplied by the superior gluteal artery which was subsequently embolised a day prior to surgical resection. The axial CT (c) and axial
T2 MRI (d) demonstrates the mass originating from the outer cortex of the right iliac bone. It has a narrow zone of transition with distinct
borders. Edema is noted in the iliac bone (B) and the gluteal musculature (M) on the ﬂuid sensitive T2 MRI sequence demonstrating the
aggressive nature of this benign lesion. Axial T2 MRI (e) 5 years postresection demonstrates unusual progression to high grade osteoblastic
osteosarcoma (arrows). Even though benign, osteoblastomas can be locally aggressive, recur or diﬀerentiate to a malignant aggressive tumor,
in this case necessitating a revision hemipelvectomy.
in the evaluation of primary bone tumors [1]. CT provides
important information regarding tumor location, margins,
presence or absence of osseous or chondroid calciﬁcation,
corticalinvolvement,andassociatedperiostealreaction.MRI
has proven superior in assessing intraarticular/intraosseous
extension and the presence of hemorrhage and intratumoral
necrosis [2, 3].
3.Recent Advances inTumor Imaging
Dynamic-enhanced MRI may help in diﬀerentiation of
reactive bone edema from tumor extension, in a malignant
lesion [4]. Tumor tissue enhances on early dynamic images;
whereas peritumoral reactive edema may not show early
phase enhancement [5–7]. This technique has the potential
to assist the surgeon in operative planning for resection of
disease. Quantitative dynamic MR imaging can quantify the
degree of tumor necrosis following preoperative chemother-
apy.Thisisbecauseactivetumorenhancesmorerapidlythan
nonviable tumor and post-treatment change [8, 9]. Thereby,
chemotherapy can be altered if the response is not adequate.
Diﬀusion-weighted imaging (DWI) is a technique based
on the fact that viable tumor restricts the diﬀusion of
water when compared to normal tissue and is depicted
as an increase in signal intensity in diﬀusion-weighted4 The Scientiﬁc World Journal
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Figure 4: 40-year-old male with a large left iliac wing expansile mass diagnosed as pelvic giant cell tumor. Plain ﬁlm (a) shows a large, lytic,
destructive lesion in the right iliac wing with indistinct margins and cortical breakthrough (arrows), with no visible matrix. Left internal
iliac artery angiogram (b) demonstrating the highly vascular nature of the tumor. Selective embolization of the superior gluteal artery (c)
demonstratingembolizationcoils(arrowheads),anddecreasedtumorvascularity.AxialT2fatsatMRI(d)andaxialpost-contrastCTimages
(e) demonstrating expansile nature of the giant cell tumor with multiple foci of necrosis (asterisk) and intervening tumor stroma. Size of
the mass increased following embolization due to internal bleeding and necrosis. Displacement of surrounding soft tissues (Iliopsoas (P),
gluteal musculature (G)), rather than invasion is illustrated. Note residual outer rim of expansile cortical bone (arrows), better appreciated
on the CT scan.The Scientiﬁc World Journal 5
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Figure 5: 61-year-old female with Mazabraud syndrome (polyostotic ﬁbrous dysplasia and soft tissue myxomas (M)). Plain ﬁlm (a)
demonstrates multiple lucent lesions with ground glass matrix in the pelvis (asterisk) and long predominantly sclerotic abnormality in
bilateral femurs (circle). Fibrous dysplasia is often described as a long lesion in the long bone. Coronal T1 (b) and STIR (c) MRI images
demonstrating multiple ﬁbrous dysplasia (F) lesions. Note that some of these maintain low to intermediate signal intensity on both T1 and
T2 images (asterisk). Axial CT (d) and axial T2 fat sat (e) MRI images demonstrating contour abnormality of the left ilium with ground glass
matrix and focal bone expansion (F). Multiple T2 bright myxomas (M) are noted in the gluteal musculature.
sequences [8]. DWI can be helpful in diﬀerentiating benign
from malignant vertebral compression fractures [10].
MR Spectroscopy can measure diﬀerent metabolites
that make up the tumors. Even though single voxel and
multivoxel MR spectroscopy have demonstrated elevated
Choline levels in many malignant tumors, it can also be
elevated in some benign tumors including giant cell tumors
[11, 12]. Hence, it is not speciﬁc enough in diagnosing
malignant tumors.
3.1. Positron Emission Tomography/Computed Tomography
(PET/CT). Presently, PET/CT machines incorporate ad-
vanced multidetector CT technology, which enables diag-
nostic quality CT images to be obtained. PET/CT is helpful
in diﬀerentiating benign lesions from the malignant ones,
assessing treatment response, and in postoperative tumor
surveillance as it is very sensitive to early tumor recurrence
[13]. Fluorine-labelled ﬂuorodeoxyglusose (FDG) is the
most commonly used PET tracer. It is preferentially taken
up by the cells, which demonstrate increase in cellular
glycolysis, seen in most malignant bone tumors and in some
benign conditions like arthritis and infection [14–16]. The
degree of uptake of the FDG tracer by the tumor cells
when compared to the normal soft tissue background is
expressed in terms of standardised uptake value (SUV), a
marker of metabolic activity of the tumor [17]. A study
involving 52 bone tumors by Aoki et al. concluded that
average SUV value for benign bone lesions to be 2.18 and
for the malignant ones to be 4.34 [18]. Round blue cell
tumors like Ewing’s sarcoma and bone lymphoma showed
the greatest FDG uptake followed by moderate uptake in
osteosarcoma and low uptake in chondrosarcoma. Some6 The Scientiﬁc World Journal
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Figure 6: 8-year-old male presented with left hip pain, diagnosed as Aneurysmal bone cyst. Plain ﬁlm (a) demonstrates large expansile lytic
lesion (arrows) involving medial left acetabulum extending to the inferior pubic rami (G: gonadal shield). Axial CT scan (b) obtained
immediately following curettage and packing with bone allograft showing relatively dense material (asterisk) within the expanded left
Ischium. Follow-up plain ﬁlm (c) ﬁve years postsurgical curettage and embolization (note the embolization coils along the medial aspect of
the hip) shows healing of the ABS with return to normal contour and course trabeculation. Unfortunately, a focus of recurrence is also noted
in the superior acetabulum (asterisk). Local recurrence is not common, but possible.
benign bone lesions, which can be FDG avid, include giant
cell tumors, aneurysmal bone cyst, osteoblastoma (likely
because of the presence of signiﬁcant amount of giant
cells) chondroblastoma, and ﬁbrous dysplasia [18, 19]. Most
benign bone lesions (like enchondroma, osteochondroma,
osteoid osteoma) do not show signiﬁcant FDG uptake [18].
4. Biopsy
Biopsy is often required to reach a speciﬁc diagnosis. Percu-
taneous image-guided biopsy is preferred over surgical open
biopsy because it is less invasive, more cost eﬀective, and
has less postprocedure morbidity. This should generally be
performed following discussions with the surgeon involved,
respecting the regional compartment anatomy. Misadven-
t u r e si nt e r m so fa p p r o a c ha n dt e c h n i q u ec a nl e a dt o
signiﬁcant complications, such as more radical surgery and
unnecessary amputation [20]. The biopsy procedure should
be performed in such a fashion that the entire biopsy tract
can be excised at the time of deﬁnitive surgery [21]. It should
be noted that contamination of adjacent compartments or
neurovascular bundles may occur as the result of biopsy
approach or procedure complications, such as hematoma
[21]. Every attempt should be made to accurately stage
disease, prior to performing the biopsy. If the lesion can
be well visualized and accurately localized by ultrasound,
we prefer this as our primary modality to help biopsy a
lesion. CT is selected when the lesion is deep, predominantly
osseous, and poorly visualized by ultrasound. With the
emergence of vertically open magnets, it is expected that MR
guided biopsies will become more popular [22].
5. The Inﬂuence of Age on the Differential
Diagnosisof PelvicTumors
Many bone tumors are to a large extent age speciﬁc
(Figure 8). Although, a number of cases fall outside the
expected range, it is of important diagnostic signiﬁcance
to consider the patient’s age when assessing osseous pelvic
tumors.
5.1. Benign Tumors. Most benign tumors occur before the
age of 40.
5.2. Osteochondroma. Osteochondroma, one of the most
common benign lesions of bone, is a cartilage-covered
bony projection (exostosis), usually pointing away from the
nearby joint. The innominate bone is involved in 5% of cases
[23]. The radiographic presentation is quite characteristic,
presenting either as a pedunculated lesion with a slender
pedicle directed away from the growth plate, or less com-
monly, a sessile growth with a broad base. A distinguishingThe Scientiﬁc World Journal 7
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Figure 7: Forty-six-year-old female with a lytic lesion in the left medial acetabulum, diagnosed as chondroblastoma. Plain ﬁlm (a) and axial
CT (b) demonstrating a lytic lesion with heterogeneous chondroid matrix and sharp scalloped margins. The tumor showed increased uptake
on bone scan (c) (B: bladder). Plain ﬁlm (d) demonstrating healed chondroblastoma following surgical curettage and cement packing.
featureofthislesioniscontinuityofthecortexandmedullary
portion of the lesion with the parent bone (Figure 2). The
typical clinical presentation is that of a nontender, painless
mass in a younger patient. There is no major variation in
size after skeletal maturity. Symptoms may be secondary in
nature, either due to compression of adjacent structures,
such as a nerve, or due to inﬂammatory changes involving
the adventitious bursa covering the cartilaginous cap. In
the pelvis, osteochondromas may be large and lead to
softtissuedisplacement.Osteochondromas,dependingupon
their anatomic location, may be more prone to trauma-
induced fracture.
In the absence of trauma, bursitis, or nerve compression,
the onset of pain in a previously asymptomatic osteo-
chondroma could indicate malignant transformation. The
extent of cartilage cap calciﬁcation is variable but must be
closely evaluated in the symptomatic exostosis. A small,
well-deﬁned cap with stippled calciﬁcation is most likely
benign; whereas a large, poorly deﬁned cap, containing
irregular or incomplete calciﬁcation, must be considered
as a possible malignancy. Any increase in the thickness of
the cartilage cap after puberty should raise concern for
malignant change. A cartilage cap more than 2.0cm thick
is suspicious for malignant transformation [23, 24]. The
patterns of calciﬁcation are variable and may be irregular;
thus, discerning benign from a malignantly transformed
lesion may be diﬃcult.
5.3. Osteoblastoma. These lesions occur most commonly in
the second and third decades of life and are approximately
t w ot i m e sm o r ec o m m o ni nm e nt h a nw o m e n[ 25, 26].
Unfortunately, the radiographic appearances of osteoblas-
toma are varied and generally nonspeciﬁc (Figure 3(a)).
They range from being osteolytic to osteosclerotic and a
spectrum of combinations in between. The characteristic
lesion consists of a geographic pattern of lysis, with or
without a rim of surrounding sclerosis [24, 25]. Osseous
expansion, cortical thinning, and a soft tissue mass may
be present, mimicking a more aggressive process (Figures
3(b), 3(c), and 3(d)). When radiographs demonstrate an
expansile, well-circumscribed, partially calciﬁed lesion, the
diagnosis of osteoblastoma should be considered. Bone
sclerosis and an exuberant periostitis are well described,
often raising concern for malignancy. Despite the benign
nature of “conventional” osteoblastoma, an inﬂammatory
response within the adjacent bone marrow and soft tissues
may lead to an aggressive appearance on MRI (Figure 3(d))
and can recur [27]. Osteoblastomas may demonstrate sec-
ondary aneurysmal bone cyst formation, similar to giant cell
tumor; however, unlike giant cell tumor, the solid portion8 The Scientiﬁc World Journal
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Figure 8: Typical ages for benign and malignant osseous pelvic tumors.
of osteoblastoma is characteristically high signal on T2-
weighted images [28].
5.4. Giant Cell Tumor. Giant cell tumors (GCTs) have peak
prevalence in the third and fourth decades of life and are
slightly more common in women than men [25, 29, 30].
Only 1% to 3% occurs in skeletally immature individuals
[29] with 98% of cases, occurring after physeal plate closure
[31]. GCT can show locally aggressive features and are
very vascular in nature. Approximately 5%–10% of giant
cell tumors are malignant [32]. It invariably involves the
epiphysis but is centered in the metaphysis. GCT in the
innominate bone favors the epiphyseal equivalent, that is,
adjacent to the sacroiliac joint or hip articulation [33].
Radiographic appearances of GCT are highly characteristic
in long bones, whereas those seen in ﬂat bone are less
speciﬁc. The sacrum is the commonest site of occurrence in
the spine (4%) [34]. Pelvic GCT is generally lytic and the
large associated soft tissue mass may resemble an aggressive
lesion demonstrating increased vascularity (Figure 4(a)).
Occasionally, sacral lesions will cross the sacroiliac joint. The
absence of internal punctate calciﬁcation, intralesional bone
formation, and signiﬁcant periostitis, unless complicated by
fracture, is helpful in GCT diagnosis [29, 30]. GCT often
demonstrates solid and cystic components, leading to the
radiological appearance of secondary aneurysmal bone cyst
formation (Figures 4(d), and 4(e)). Fluid/ﬂuid levels may
be identiﬁed but are not speciﬁc to GCT [31]. The primary
role of MRI is to deﬁne intraosseous, intraarticular and
soft tissue involvement (Figure 4(d)). The lesion typically
demonstrates low T1 and heterogeneous T2 signal intensity.
Ofnote,thesolidcomponenthasacharacteristicappearance;
demonstrating low signal on both T1- and T2-weighted
images. This low-to-intermediate signal intensity in the
solid portion of the tumor has been considered secondary
to the presence of hemosiderin, high collagen content, or
high cellularity [29, 30]. Inhomogeneity of internal signalThe Scientiﬁc World Journal 9
reﬂects necrosis and cystic change. Haemosiderin changes
may present, from previous hemorrhage.
5.5. Fibrous Dysplasia. Fibrous dysplasia is a benign devel-
opmental abnormality of bones, of unknown cause, in which
there is failure of normal ossiﬁcation, deposition of ﬁbrous
tissue and modulation deformity. Two broad categories are
described: monostotic and polyostotic. Monostotic ﬁbrous
dysplasia is more common than the polyostotic form,
and accounts for 75 to 80% of cases [35]. Polyostotic
type is, however, much more common in two syndromes.
In Mazabraud syndrome, ﬁbrous dysplasia is associated
with soft tissue myxomas, lesions which are predominantly
intramuscular in nature (Figure 5). In McCune Albright
syndrome, polyostotic ﬁbrous dysplasia is associated with
sexualprecocityandskinpigmentation.Mostcasesofﬁbrous
dysplasia are asymptomatic, so true incidence is unknown.
Unfortunately, there are very few deﬁning features of the
disease. This entity can be seen in a patient of any age
and the radiographic appearances vary. In the pelvis, typical
ﬁbrousdysplasialesionsarelyticandparticularlyoccurinthe
iliac bones (Figure 5(a)). There is a classical description of a
“ground glass” matrix, and patchy sclerosis, as it resolves. It
is very unusual to observe a periosteal reaction. The signal
intensity characteristics of ﬁbrous dysplasia vary and are
nonspeciﬁc. When associated with secondary bone cyst, they
can demonstrate ﬂuid-ﬂuid levels [36]. Typically, lesions
tend to have low signal intensity on T1- and T2-weighted
sequences (Figures 5(b), and 5(c)); however, they may be of
higher signal intensity on T2 [6].
5.6. Aneurysmal Bone Cyst. The World Health Organization
deﬁnes aneurysmal bone cyst (ABC) as an expansile oste-
olytic lesion (Figure 6) with blood-ﬁlled spaces separated
by connective tissue septa containing trabeculae of bone or
osteoid, as well as osteoclast giant cells [37]. These lesions
a r em o s tc o m m o ni np a t i e n t sl e s st h e n2 0y e a r so fa g eb u t
can be seen in older patients. These lesions are slightly more
c o m m o ni nf e m a l e st h a nm a l e s[ 38]. Fifty percent of ﬂat
bone ABCs are found in the pelvis [39].
The origin of ABCs is not well understood. Authors
in the past have suggested these lesions may develop de
novo in bone or maybe secondary to hemorrhagic degen-
eration of a preexisting lesion such as a giant cell tumor,
hemangioma, osteoblastoma, or ﬁbrous dysplasia; however,
elements deﬁnitive of other osseous lesions are not usually
found in pathological specimens, and as such, the etiology of
ABC remains controversial [40, 41].
Lesions are typically eccentric and lytic, with well-cir-
cumscribed borders. The overlying cortex is expansile and
thinned (Figure 6(b)). A sclerotic rim and internal trabecu-
lation may be present. Computed tomography and magnetic
resonance imaging may show cystic spaces with ﬂuid-ﬂuid
levels and contrast enhancing internal septa. High-to-low
T1- and-T2 weighted signal intensity in the ﬂuid-ﬂuid levels
ispresumablyduetobloodproductsofvaryingage.OnMRI,
edema may be present in the surrounding bone [40].
Needle biopsy can be attempted for diagnosis; however,
the specimens may only yield blood products and can be
nondiagnostic. Open biopsy with frozen section is more
likely to provide deﬁnitive diagnosis [41].
5.7. Chondroblastoma. A Chondroblastoma is considered a
benign cartilage tumor originating in the epiphysis, often
with an aggressive appearance. It usually presents clinically
with pain in the 2nd decade of life. It typically appears
as an expansile lytic lesion with a faint chondroid matrix,
scalloped borders, and an intact but thinned cortex (Figures
7(a), and 7(b)). It characteristically has extensive bone
marrow edema on MRI and can show increased uptake
on bone scan (Figure 7(c)). It can demonstrate ﬂuid-ﬂuid
levels. The femoral head is a more preferred location for
chondroblastomathanthepelvis.Thesetumorsarenormally
treated by curettage and packing (Figure 7(d)). There is a
highriskoflocalrecurrenceandonrareoccasions,therehave
been pulmonary metastasis.
6. Summary
We have discussed and illustrated common benign tumors
that aﬀect the skeletal pelvis. Although there is a wide
diﬀerential diagnosis for skeletal pelvic tumors, proper
use of plain radiography, CT, and MR imaging can help
narrow the diagnostic considerations and clearly deﬁne the
anatomical extent. Biopsy may ultimately be necessary for
ﬁnal diagnosis.
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